The involvement of various factors such as hyperglycemia, angiotensin II, advanced glycation end products (AGEs), oxidative stress, transforming growth factor β (TGF-β), plasminogen activator inhibitor 1 (PAI-1), and connective tissue growth factor (CTGF) in DN has been reported [5]. The gene discussed is CCN2; the disease is liver dysplastic nodule.